Liquid Stenabolic (SR-9009) 20mg/ml, 30ml

SR9009 (Liquid Stenabolic) – EliteBiogenix Research Compound Overview

EliteBiogenix is proud to provide premium-quality SR9009 (Liquid Stenabolic), a cutting-edge research compound designed for scientific exploration. SR9009 is a potent Rev-ErbA protein agonist, a protein expressed in key areas of the body, including the liver and skeletal muscle systems. Research indicates that SR9009 plays a significant role in regulating circadian rhythms, influencing lipid and glucose metabolism, and modulating fat-storing cells. While not classified as a SARM (Selective Androgen Receptor Modulator), SR9009 binds to Rev-ErbA, producing effects comparable to SARMs and beyond.

Developed in 2013 by Scripps Research, SR9009 has demonstrated remarkable potential in preclinical studies. Early research on mice revealed its ability to enhance metabolic activity, promote skeletal muscle growth, and support fat loss without impacting endogenous testosterone levels. For researchers seeking a high-quality compound for cutting-edge studies, EliteBiogenix is the trusted source to buy SR9009 online.

Key Research Findings on SR9009

SR9009 has shown a wide range of effects in preclinical studies, including:

• Boosted Resting Metabolic Rate: Enhances energy expenditure, supporting fat loss.
• Cardiovascular Protection: Promotes heart health and resilience under stress.
• Circadian Rhythm Regulation: Helps regulate sleep patterns and metabolic cycles.
• Improved Endurance: Increases exercise capacity and stamina.
• Weight Management: Supports fat reduction and lean muscle retention.
• Cholesterol Regulation: Lowers cholesterol levels for improved metabolic health.
• Anti-Inflammatory Properties: Reduces bodily inflammation.
• Arterial Health: Manages arterial plaque buildup.

SR9009 has also shown promise in addressing conditions such as heart failure, COPD (Chronic Obstructive Pulmonary Disease), and metabolic syndrome. However, further research on human subjects is required to fully understand its potential.

SR9009 and Circadian Rhythm

SR9009 has been shown to influence circadian behavior and gene expression in preclinical models. By targeting Rev-ErbA, it modulates metabolic genes in the liver, skeletal muscle, and adipose tissues, leading to increased energy expenditure. In studies involving diet-induced obese mice, SR9009 reduced fat mass, improved dyslipidemia, and normalized hyperglycemia. These findings suggest that SR9009 may hold potential for addressing sleep disorders and metabolic diseases linked to circadian rhythm disruptions.

SR9009 and Energy Metabolism

Research on SR9009 highlights its ability to regulate energy homeostasis. In studies involving goldfish, SR9009 inhibited feeding, reduced body weight, and lowered plasma glucose levels. It also decreased lipid levels and lipogenic enzyme activity while increasing glycolysis in the liver. These effects indicate that SR9009 promotes a negative energy balance by optimizing lipid and glucose metabolism, making it a compelling compound for metabolic research.

SR9009 and Endurance

A 2013 study demonstrated that mice treated with SR9009 exhibited significantly improved endurance, running longer distances and durations compared to untreated subjects. This effect is attributed to SR9009’s ability to increase mitochondrial density and enhance respiratory capacity. Unlike other endurance-enhancing compounds, SR9009 achieves this by regulating gene networks that govern mitochondrial function, offering a unique mechanism of action.

SR9009 and Cardiovascular Health

SR9009 has demonstrated cardio-protective properties in preclinical models. Studies on REV-ERB-deficient mice revealed that SR9009 could still protect the heart from pressure overload, even in the absence of REV-ERB proteins. This suggests that SR9009’s cardio-protective effects operate independently of REV-ERB, making it a valuable compound for cardiovascular research.

SR9009 and Lung Health

In vitro studies have shown that SR9009 can reduce inflammation in lung injury models by suppressing TLR4-induced NF-κB activation. It has also been shown to improve metabolic markers such as arterial PaCO2, PaO2, and blood pH, suggesting potential benefits for acute lung injury management. Additionally, SR9009 has demonstrated anti-tumor effects in small cell lung cancer (SCLC) models, making it a promising candidate for oncology research.

SR9009 (Liquid Stenabolic) Product Details

• CAS Number: 1379686-30-2
• Molecular Formula: C20H24ClN3O4S
• Molar Mass: 437.940 g/mol
• Classification: Rev-ErbA Agonist
• Storage: Store in a cool, dry place away from direct sunlight to maintain stability.

Product Specifications:

• 50ml liquid SR9009 per bottle
• Concentration: 20mg/ml
• Includes a graduated 1mL glass pipette for precise measurement
• UV-resistant glass bottle to minimize degradation
• Tamper-proof seal for secure delivery
• Less than 5% concentration variance for consistency
• Formulated to prevent evaporation during storage

Important Note: SR9009 is intended for laboratory research purposes only. It is not approved by the FDA for human consumption and should not be used as a dietary or sports supplement.

References

1. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature
2. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nature
3. SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. Frontiers in Cardiovascular Medicine
4. SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis. Hindawi
5. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy. NCBI
6. REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish. MDPI